TY - JOUR
T1 - Development and optimization of nanoparticles loaded with erucin, a dietary isothiocyanate isolated from Eruca sativa
T2 - Antioxidant and antiproliferative activities in ehrlich-ascites carcinoma cell line
AU - Singh, Sharabjit
AU - Singh, Gurdeep
AU - Attri, Shivani
AU - Kaur, Prabhjot
AU - Rashid, Farhana
AU - Bedi, Neena
AU - Haque, Shafiul
AU - Janahi, Essam M.
AU - Arora, Saroj
N1 - Publisher Copyright:
Copyright © 2023 Singh, Singh, Attri, Kaur, Rashid, Bedi, Haque, Janahi and Arora.
PY - 2023/1/25
Y1 - 2023/1/25
N2 - The study on Erucin (ER) has gained interest of nutraceutical and pharmaceutical industries because of its anti-cancer properties. Erucin is an isothiocyanate obtained from the seeds of Eruca sativa which possess certain drawbacks such as poor aqueous solubility and bioavailability. Therefore, the present study aimed at developing ER-cubosomes (CUB) by solvent evaporation technique followed by applying Central Composite Design to optimize ER loaded cubosomes. For this purpose, independent variables selected were Monoolein (MO) as lipid and Pluronic-84 (P-84) as a stabilizer whereas dependent variables were particle size, percentage of ER loading and percentage of its entrapment efficiency. The cubosomal nanocarriers exhibited particle size in the range of 26 nm, entrapment efficiency of 99.12 ± 0.04% and drug loading of 3.96 ± 0.0001%. Furthermore, to investigate the antioxidant potential, we checked the effect of ER and ER-CUB by DNA nicking assay, DDPH assay and Phosphomolybdate assay, and results showed significant improvement in antioxidant potential for ER-CUB than ER. Similarly, ER-CUB showed enhanced anticancer activity with a marked reduction in IC50 value than ER in MTT assay. These results suggested that ER-CUB produced notable escalation in antioxidant potential and enhanced anticancer activity than ER.
AB - The study on Erucin (ER) has gained interest of nutraceutical and pharmaceutical industries because of its anti-cancer properties. Erucin is an isothiocyanate obtained from the seeds of Eruca sativa which possess certain drawbacks such as poor aqueous solubility and bioavailability. Therefore, the present study aimed at developing ER-cubosomes (CUB) by solvent evaporation technique followed by applying Central Composite Design to optimize ER loaded cubosomes. For this purpose, independent variables selected were Monoolein (MO) as lipid and Pluronic-84 (P-84) as a stabilizer whereas dependent variables were particle size, percentage of ER loading and percentage of its entrapment efficiency. The cubosomal nanocarriers exhibited particle size in the range of 26 nm, entrapment efficiency of 99.12 ± 0.04% and drug loading of 3.96 ± 0.0001%. Furthermore, to investigate the antioxidant potential, we checked the effect of ER and ER-CUB by DNA nicking assay, DDPH assay and Phosphomolybdate assay, and results showed significant improvement in antioxidant potential for ER-CUB than ER. Similarly, ER-CUB showed enhanced anticancer activity with a marked reduction in IC50 value than ER in MTT assay. These results suggested that ER-CUB produced notable escalation in antioxidant potential and enhanced anticancer activity than ER.
KW - antioxidant assay
KW - central composite design
KW - colon cancer
KW - cubosomes
KW - ehrlich ascites carcinoma
KW - erucin
UR - https://www.scopus.com/pages/publications/85147669023
U2 - 10.3389/fphar.2022.1080977
DO - 10.3389/fphar.2022.1080977
M3 - Artículo
AN - SCOPUS:85147669023
SN - 1663-9812
VL - 13
JO - Frontiers in Pharmacology
JF - Frontiers in Pharmacology
M1 - 1080977
ER -